 |
 |
|
|
|  PubMed
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
18 January 2000 | Volume 132 Issue 2 | Pages 144-150
Acquired C1 esterase inhibitor deficiency is a rare condition associated with autoimmune or low-grade lymphoproliferative disorders. Adults or elderly patients are most commonly affected. The diagnosis is suspected when patients present with recurrent angioedema and low serum levels of C4 with normal levels of C3. Low levels of C1q and low C1 esterase inhibitor activity confirm the diagnosis.
In this paper, we summarize experience with 22 cases of acquired C1 esterase inhibitor deficiency in the context of a review of the published literature on diagnosis and treatment of this condition.
Author and Article Information
From Mayo Clinic, Rochester, Minnesota.
Grant Support: From the Mayo Foundation.
Requests for Reprints: Svetomir N. Markovic, MD, PhD, Division of Hematology, Department of Internal Medicine, Mayo Clinic, 200 First Street SW, Rochester MN, 55901. For reprint orders in quantities exceeding 100, please contact the Reprints Coordinator; phone, 215-351-2657; e-mail, reprints{at}mail.acponline.org.
Current Author Addresses: Drs. Markovic, Inwards, and Phyliky: Division of Hematology, Department of Internal Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55901.
Dr. Frigas: Division of Allergy and Outpatient Infectious Diseases, Department of Internal Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55901. CLINICAL REVIEW
Acquired C1 Esterase Inhibitor Deficiency
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Facebook 
Reddit 
Technorati 
Twitter What's this?
Related articles in Annals:
This article has been cited by other articles:
|
|
 |
|
  D Sanchez-Cano, J. Callejas-Rubio, M. Lara-Jimenez, M Lopez-Trascasa, M Circadi, and N Ortego-Centeno Successful use of rituximab in acquired C1 inhibitor deficiency secondary to Sjogren's syndrome Lupus, March 1, 2008; 17(3): 228 - 229. [PDF]
|
|
|
|
 |
|
 A. McLean-Tooke, C. Stroud, A. Sampson, and G. Spickett Falsely normal C4 in a case of acquired C1 esterase inhibitor deficiency J. Clin. Pathol., May 1, 2007; 60(5): 565 - 566. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. C. Sulpizio, M. A. Pullen, R. M. Edwards, J. B. Louttit, R. West, and D. P. Brooks Mechanism of Vasopeptidase Inhibitor-Induced Plasma Extravasation: Comparison of Omapatrilat and the Novel Neutral Endopeptidase 24.11/Angiotensin-Converting Enzyme Inhibitor GW796406 J. Pharmacol. Exp. Ther., December 1, 2005; 315(3): 1306 - 1313. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Sondhi, M. Lippmann, and G. Murali Airway Compromise Due to Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema: Clinical Experience at a Large Community Teaching Hospital Chest, August 1, 2004; 126(2): 400 - 404. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. C. Sulpizio, M. A. Pullen, R. M. Edwards, and D. P. Brooks The Effect of Acute Angiotensin-Converting Enzyme and Neutral Endopeptidase 24.11 Inhibition on Plasma Extravasation in the Rat J. Pharmacol. Exp. Ther., June 1, 2004; 309(3): 1141 - 1147. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M M Gompels, R J Lock, J E Morgan, J Osborne, A Brown, and P F Virgo A multicentre evaluation of the diagnostic efficiency of serological investigations for C1 inhibitor deficiency J. Clin. Pathol., February 1, 2002; 55(2): 145 - 147. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. C. Nzeako, E. Frigas, and W. J. Tremaine Hereditary Angioedema: A Broad Review for Clinicians Arch Intern Med, November 12, 2001; 161(20): 2417 - 2429. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B Y. Thong, J Thumboo, H S Howe, and P H Feng Life-threatening angioedema in systemic lupus erythematosus Lupus, April 1, 2001; 10(4): 304 - 308. [Abstract] [PDF]
|
|
|
|
 |
|
 D. Zauli, G. Deleonardi, A. Grassi, R. Bortolotti, F. Lari, G. Ballardini, and F. B. Bianchi Chronic Urticaria Arch Dermatol, April 1, 2001; 137(4): 504 - 505. [Full Text] [PDF]
|
|
|
|
 |
|
 T. Caballero, M. Concepcion Lopez-Serrano, and M. Lopez-Trascasa Acquired C1 Esterase Inhibitor Deficiency Ann Intern Med, November 21, 2000; 133(10): 837 - 837. [Full Text] [PDF]
|
|
|
|
|
|
A. P. Kaplan Acquired C1 Esterase Inhibitor Deficiency Ann Intern Med, November 21, 2000; 133(10): 838 - 838. [Full Text] [PDF]
|
|
|
|
|
|
T. Grunewald Acquired C1 Esterase Inhibitor Deficiency Ann Intern Med, November 21, 2000; 133(10): 837 - 837. [Full Text] [PDF]
|
|
|
|
|
|
M. Cicardi, A. Agostoni, and A. E. Davis III Acquired C1 Esterase Inhibitor Deficiency Ann Intern Med, November 21, 2000; 133(10): 837 - 838. [Full Text] [PDF]
|
|
|
|
|
|
A. Csepregi and E. Nemesanszky Acquired C1 Esterase Inhibitor Deficiency Ann Intern Med, November 21, 2000; 133(10): 838 - 839. [Full Text] [PDF]
|
|
|
|
 |
|
 M. D. Hill, P. A. Barber, J. Takahashi, A. M. Demchuk, T. E. Feasby, and A. M. Buchan Anaphylactoid reactions and angioedema during alteplase treatment of acute ischemic stroke Can. Med. Assoc. J., May 1, 2000; 162(9): 1281 - 1284. [Abstract] [Full Text] [PDF]
|
|
